arrow
M

Muhammad Asad Maqbool

Mayo Clinic
H指数:2
被引数:20

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma

DNA拷贝数模式揭示了IDH突变型星形细胞瘤的预后标志物,并阐明了其进化机制。

2026-02-280
PRE
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, IDH-wildtype

IDH野生型星形细胞瘤的病理学诊断与分子分型在临床、影像学及基因组学改变方面的比较

2026-01-010
OA
Pembrolizumab efficacy in recurrent adult-type diffuse gliomas

帕博利珠单抗在复发成人型弥漫性胶质瘤中的疗效

2025-11-010
OAAI
Multivariate survival risk stratification in GBMs lacking necrosis and microvascular proliferation

胶质母细胞瘤中缺乏坏死和微血管增生的多变量生存风险分层

2025-11-010
OAAI
Clinical utility of RANO 2.0 for response assessment to immunotherapy in recurrent gliomas

RANO 2.0在复发性胶质瘤免疫治疗反应评估中的临床应用价值

2025-11-010
PRE
WSD0922-FU THERAPY IN PATIENTS WITH EGFR MUTANT GLIOBLASTOMA - UPDATES FROM THE DOSE EXPANSION COHORTS OF A FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL (MC1914)

WSD0922-FU疗法在EGFR突变型胶质母细胞瘤患者中的应用——来自一项首次人体I期临床试验(MC1914)剂量扩展队列的更新信息

2025-11-010
OAAI
DNA copy number clustering reveals alterations that influence survival in primary IDH-mutant astrocytoma patients

DNA拷贝数聚类分析揭示了影响IDH突变型星形细胞瘤患者生存的基因改变。

2025-11-010
OAAI
Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma

转录组分析鉴定出一种潜在的针对贝伐珠单抗耐药胶质母细胞瘤的治疗靶点

2025-10-220
OAAI
Characterizing the molecular and spatial heterogeneity of midline gliomas in adults: a single institution analysis

表征成人中线胶质瘤的分子和空间异质性: 单一机构分析

2025-03-010
PRE